Clinical Trials Browser

Interventional × Neoplasms, Plasma Cell × Simvastatin × Clear all

NCT01332617 2017-12-29

Phase II Study of Simvastatin for Relapsed/Refractory Myeloma

Phase 2 Withdrawn

Multiple Myeloma, Neoplasms, Plasma Cell